Literature DB >> 32053483

Regional and socio-economic variation in survival after a pancreatic cancer diagnosis in Denmark.

Henriette Engberg1, Marianne Steding-Jessen, Inge Øster, Jens Winther Jensen, Claus Wilki Fristrup, Henrik Møller.   

Abstract

INTRODUCTION: Pancreatic cancer is among the most lethal malignancies with a five-year survival of about 5%, and the only curative treatment is surgical resection. Denmark consists of five governmental regions and has four surgical centres. Our aim was to explore the regional and socio-economic differences in overall survival following a pancreatic cancer diagnosis in Denmark.
METHODS: We included a total of 5,244 pancreatic cancer patients (WHO International Classification of Diseases, tenth version C25) registered in the Danish Pancreatic Cancer Database during 2012-2017. The data sources used were the Danish Civil Registration System, the Danish National Patient Registry and the Danish national registers on education and income at Statistics Denmark. Cox regression analysis was used to examine all-cause mortality of pancreatic cancer patients by region of residence and socio-economic status.
RESULTS: Compared to The Capital Region, there was an excess mortality in the Central Denmark Region and the North Denmark Region in both men and women, whereas no increased mortality was observed in the Region of Southern Denmark or in Region Zealand. Estimates were adjusted for age, year of diagnosis and comorbidity. Adjustment for surgical resection greatly attenuated the variation in survival between the regions.
CONCLUSIONS: We found significant differences in overall survival across the five Danish regions following a diagnosis of pancreatic cancer. The regional variation in survival was largely attributable to differences in the propensity to use surgical resection. FUNDING: none. TRIAL REGISTRATION: not relevant. Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Year:  2020        PMID: 32053483

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  3 in total

1.  Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.

Authors:  Nina Afshar; Dallas R English; Roger L Milne
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

2.  Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice.

Authors:  Valérie Jooste; Leila Bengrine-Lefevre; Sylvain Manfredi; Valérie Quipourt; Pascale Grosclaude; Olivier Facy; Côme Lepage; François Ghiringhelli; Anne-Marie Bouvier
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

3.  Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study.

Authors:  Sung Hoon Jeong; Hyeon Ji Lee; Choa Yun; Il Yun; Yun Hwa Jung; Soo Young Kim; Hee Seung Lee; Sung-In Jang
Journal:  BMC Cancer       Date:  2022-08-27       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.